Evaluation and management of the renal mass

Medical Clinics of North America

Volumn 95, Issue 1, 2011, Pages 179-189

  Chen, David Y T ^a   Uzzo, Robert G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Evaluation; Renal cell carcinoma; Surgery; Treatment

Indexed keywords

ANGIOGENESIS INHIBITOR; CONTRAST MEDIUM; CREATININE; GADOLINIUM;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; CRYOABLATION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; GENERAL PRACTICE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; KIDNEY CARCINOMA; KIDNEY FUNCTION; LABORATORY TEST; METASTASIS; MINIMALLY INVASIVE SURGERY; NEPHRECTOMY; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; ULTRASOUND;

AGE FACTORS; CARCINOMA, RENAL CELL; CONTINENTAL POPULATION GROUPS; HUMANS; KIDNEY NEOPLASMS; PRIMARY HEALTH CARE; SEX FACTORS; UROLOGIC SURGICAL PROCEDURES;

EID: 78649347932     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.08.021     Document Type: Review

References (33)

1. Parsons J.K., Schoenberg M.S., Carter H.B. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology 2001, 57(6):1013-1015.
2. Chow W.H., Devesa S.S., Warren J.L., et al. Rising incidence of renal cell cancer in the United States. JAMA 1999, 281(17):1628-1631.
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
4. Kane C.J., Mallin K., Ritchey J., et al. Renal cell cancer stage migration: analysis of the national cancer data base. Cancer 2008, 113(1):78-83.
5. Chow W.H., Devesa S.S. Contemporary epidemiology of renal cell cancer. Cancer J 2008, 14(5):288-301.
6. Tsui K.H., Shvarts O., Smith R.B., et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000, 163(2):426-430.
7. Jemal A., Ward E., Thun M. Declining death rates reflect progress against cancer. PLoS One 2010, 5(3):e9584.
8. Motzer R.J., Bacik J., Murphy B.A., et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Oncol 2002, 20(1):289-296.
9. Available at: . Accessed September 29, 2010. http://www.nephron.com/MDRD_GFR.cgi.
10. Lane B.R., Demirjian S., Weight C.J., et al. Performance of the chronic kidney disease-epidemiology study equations for estimating glomerular filtration rate before and after nephrectomy. J Urol 2010, 183(3):896-901.
11. Zagoria R.J. Imaging of small renal masses: a medical success story. AJR Am J Roentgenol 2000, 175(4):945-955.
12. Tsui K.H., Shvarts O., Barbaric Z., et al. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. J Urol 2000, 163(2):437-441.
13. Szolar D.H., Kammerhuber F., Altziebler S., et al. Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small(< 3-cm) renal masses. Radiology 1997, 202(1):211-217.
14. Ledneva E., Karie S., Launay-Vacher V., et al. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency. Radiology 2009, 250(3):618-628.
15. Motzer R.J., Agarwal N., Beard C., et al. NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw 2009, 7(6):618-630.
16. Lane B.R., Samplaski M.K., Herts B.R., et al. Renal mass biopsy-a renaissance?. J Urol 2008, 179(1):20-27.
17. Frank I., Blute M.L., Cheville J.C., et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003, 170(6 Pt 1):2217-2220.
18. Maturen K.E., Nghiem H.V., Caoili E.M., et al. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol 2007, 188(2):563-570.
19. Robson C.J. Radical nephrectomy for renal cell carcinoma. J Urol 1963, 89:37-42.
20. Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001, 166(1):6-18.
21. McKiernan J., Simmons R., Katz J., et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002, 59(6):816-820.
22. Huang W.C., Elkin E.B., Levey A.S., et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes?. J Urol 2009, 181(1):55-61. [discussion: 61-2].
23. Thompson R.H., Boorjian S.A., Lohse C.M., et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008, 179(2):468-471. [discussion: 472-3].
24. Campbell S.C., Novick A.C., Belldegrun A., et al. Guideline for management of the clinical T1 renal mass. J Urol 2009, 182(4):1271-1279.
25. Hollenbeck B.K., Taub D.A., Miller D.C., et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?. Urology 2006, 67(2):254-259.
26. Uchida M., Imaide Y., Sugimoto K., et al. Percutaneous cryosurgery for renal tumours. Br J Urol 1995, 75(2):132-136. [discussion: 136-7].
27. Zlotta A.R., Wildschutz T., Raviv G., et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997, 11(4):251-258.
28. Kunkle D.A., Egleston B.L., Uzzo R.G. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008, 179(4):1227-1233. [discussion: 1233-4].
29. Chawla S.N., Crispen P.L., Hanlon A.L., et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006, 175(2):425-431.
30. Flanigan R.C., Salmon S.E., Blumenstein B.A., et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001, 345(23):1655-1659.
31. Coppin C., Porzsolt F., Awa A., et al. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev 2005, 1. CD001425.
32. Pal S.K., Figlin R.A. Renal cell carcinoma therapy in 2010: many options with little comparative data. Clin Adv Hematol Oncol 2010, 8(3):191-200.
33. Motzer R.J., Hutson T.E., Tomczak P., et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009, 27(22):3584-3590.